Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Zhiwei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8031-6547; OpenAlex author ID A5100409067. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 6

  1. Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer. Co-author DOI 10.1016/j.jncc.2022.08.006↗
  2. LINC01559 accelerates pancreatic cancer cell proliferation and migration through YAP-mediated pathway. Co-author DOI 10.1002/jcp.29288↗
  3. CSN6 expression is associated with pancreatic cancer progression and predicts poor prognosis. Co-author DOI 10.1080/15384047.2019.1632143↗
  4. DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression. First author DOI 10.1158/1078-0432.ccr-17-0387↗
  5. KLF4-Mediated Suppression of CD44 Signaling Negatively Impacts Pancreatic Cancer Stemness and Metastasis. First author DOI 10.1158/0008-5472.can-15-1691↗
  6. Vitamin D receptor signaling and pancreatic cancer cell EMT. Co-author DOI 10.2174/1381612821666141211151138↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Changjie Lou · 2 shared papers, 2019–2020 · strength 0.21
  2. Yanqiao Zhang · 2 shared papers, 2019–2020 · strength 0.21
  3. Keping Xie · 3 shared papers, 2015–2017 · strength 0.20
  4. Daoyan Wei · 2 shared papers, 2016–2017 · strength 0.12
  5. Yongmin Yan · 2 shared papers, 2016–2017 · strength 0.12
  6. Xiangsheng Zuo · 2 shared papers, 2016–2017 · strength 0.12
  7. Yuanlong Gu · 1 shared paper, 2020 · strength 0.11
  8. Jiaqi Shi · 1 shared paper, 2019 · strength 0.10
  9. Feng Jiao · 1 shared paper, 2022 · strength 0.09
  10. Zheng Wang · 1 shared paper, 2022 · strength 0.09
  11. Tao Zhang · 1 shared paper, 2022 · strength 0.09
  12. Qingyong Ma · 1 shared paper, 2022 · strength 0.09
  13. Liwei Wang · 1 shared paper, 2022 · strength 0.09
  14. Chunyi Hao · 1 shared paper, 2022 · strength 0.09
  15. Gang Ren · 1 shared paper, 2022 · strength 0.09
  16. Jie Chen · 1 shared paper, 2022 · strength 0.09
  17. Dan Cao · 1 shared paper, 2022 · strength 0.09
  18. Jian Wang · 1 shared paper, 2022 · strength 0.09
  19. Yongrui Bai · 1 shared paper, 2022 · strength 0.09
  20. Zhihong Zhang · 1 shared paper, 2022 · strength 0.09
  21. Yongwei Sun · 1 shared paper, 2022 · strength 0.09
  22. Ji Li · 1 shared paper, 2022 · strength 0.09
  23. Jianping Xiong · 1 shared paper, 2022 · strength 0.09
  24. Jun Zhou · 1 shared paper, 2022 · strength 0.09
  25. Feng‐Hua Wang · 1 shared paper, 2022 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.